Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

SELL
$38.82 - $54.59 $3,882 - $5,459
-100 Reduced 0.25%
40,383 $1.63 Million
Q3 2022

Oct 28, 2022

BUY
$48.29 - $71.27 $4,829 - $7,127
100 Added 0.25%
40,483 $2.1 Million
Q2 2022

Aug 01, 2022

BUY
$38.13 - $76.93 $3,813 - $7,693
100 Added 0.25%
40,383 $1.91 Million
Q4 2021

Jan 24, 2022

SELL
$60.19 - $97.37 $24,076 - $38,948
-400 Reduced 0.98%
40,283 $3.01 Million
Q3 2021

Oct 25, 2021

SELL
$41.02 - $58.65 $32,816 - $46,920
-800 Reduced 1.93%
40,683 $2.31 Million
Q2 2021

Jul 21, 2021

SELL
$43.76 - $53.11 $61,264 - $74,354
-1,400 Reduced 3.26%
41,483 $1.83 Million
Q1 2021

Apr 22, 2021

SELL
$41.69 - $54.95 $29,183 - $38,465
-700 Reduced 1.61%
42,883 $2.12 Million
Q3 2020

Nov 06, 2020

SELL
$43.36 - $53.53 $39,024 - $48,177
-900 Reduced 2.02%
43,583 $0
Q2 2020

Jul 21, 2020

SELL
$46.37 - $57.58 $4,637 - $5,758
-100 Reduced 0.22%
44,483 $2.23 Million
Q1 2020

Apr 29, 2020

SELL
$40.22 - $62.0 $128,704 - $198,400
-3,200 Reduced 6.7%
44,583 $2.29 Million
Q4 2019

Jan 24, 2020

BUY
$57.95 - $66.61 $516,218 - $593,361
8,908 Added 22.91%
47,783 $2.95 Million
Q3 2019

Oct 24, 2019

SELL
$60.08 - $88.17 $42,056 - $61,719
-700 Reduced 1.77%
38,875 $2.34 Million
Q2 2019

Jul 18, 2019

SELL
$81.3 - $97.35 $48,780 - $58,410
-600 Reduced 1.49%
39,575 $3.34 Million
Q1 2019

May 07, 2019

BUY
$69.08 - $105.66 $7,598 - $11,622
110 Added 0.27%
40,175 $3.84 Million
Q4 2018

Jan 28, 2019

BUY
$65.41 - $84.65 $10,858 - $14,051
166 Added 0.42%
40,065 $2.84 Million
Q3 2018

Nov 02, 2018

BUY
$85.46 - $126.37 $9,315 - $13,774
109 Added 0.27%
39,899 $3.41 Million
Q1 2018

May 01, 2018

BUY
$57.91 - $92.15 $75,283 - $119,795
1,300 Added 3.38%
39,790 $3.22 Million
Q3 2017

Oct 30, 2017

BUY
$37.91 - $46.8 $11,372 - $14,040
300 Added 0.79%
38,490 $1.8 Million
Q2 2017

Aug 11, 2017

BUY
N/A
38,190
38,190 $1.37 Million

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $106M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track New York State Teachers Retirement System Portfolio

Follow New York State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on New York State Teachers Retirement System with notifications on news.